Skip to content

Effect of Ayurvedic Medicine in Cervical Spondylosis.

Randomized Control Trial on Erandamula Ghanavati With Nasya In Manyagraha With Special Reference To Cervical Spondylosis.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/12/016727
Enrollment
104
Registered
2018-12-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: 1) Erandamula Ghanavati 2) Anu Taila for Nasya: Erandamula Ghanavati will be given in the dose of 500mg for each of two times per day with lukewarm water. Anu Tail Nasya administration

Sponsors

Solanke Sunil Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients having sign and symptoms of Manyagraha according to classics. 2. Radiological changes, degenerative changes in cervical spine. 3. The Oswestry neck disability questionnaire, which has been described in criteria of assessment will be taken in to account. 4. Patient willing and able to participate in the study. 5. Neck pain more than three month.

Exclusion criteria

Exclusion criteria: 1)History of any fracture of vertebral joint/ surgical/ diagnostic intervention with reference to affected joints will be excluded. 2)The patient who had fix joint or having developed contracture not be included in study. 3)Patient who are not fit for Nasya. 4) Patient with uncontrolled hypertension (=160/100mm of Hg) and uncontrolled diabetes (Blood sugar level fasting >150mg/dl and post prandial >250mg/dl) will be ruled out. 5) Patient with evidence of malignancy. 6) Patient on prolonged (=6weeks) medication with corticosteroids, nonsteroidal anti-inflammatory drug, antidepressants, anticholinergic etc. or any drugs that may influence on the outcome of the study. 7) Patient who have a past history of any other systemic disorders will be excluded. 8) Pregnant / lactating women. 9) Patients who had participated in any other clinical trial since last six months.

Design outcomes

Primary

MeasureTime frame
1)To study effect of oral administration of Erandamula Ghanavati with Anu Taila Nasya particularly on Oswestry Neck Disability Questionnaire and to compare it’s effect with the effect of oral administration of Panchatiktaghrita Guggulu with Anu Tail Nasya.Timepoint: 1)On zero day assessments i.e. B.T. value. 2)For trial Group Panchatiktaghrita Guggulu with Anutail Nasya and for Control Group Erandamula Ghanavati with Anutail Nasya will be given for 21 days 3)Followed up and assessment done on 7th, 14th, 21st day. 4)Final assessment will be done on 28th day

Secondary

MeasureTime frame
1. To study of Manyagraha with reference to Cervical Spondylosis. 2. To study Cervical Spondylosis from modern point of view.Timepoint: One and half year

Countries

India

Contacts

Public ContactPrakash Ramnarayan Kabra

Government Ayurved College And Hospital, Nagpur.

kabraprakash2711@gmail.com9225226567

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026